Movers and Shakers Today

 Top.Gainers
 
  Top.Gainers
 
Follow  Message
 
 
 
Top.Gainers highlighting the top gainers of the day, providing timely updates and insights on the market's highest achievers.
 

•  20 Jan 2026
 

•   ACHC  
   
  -1.11%
•   AKAN  
   
  +2.27%
•   CRVS  
   
  +13.58%
•   ENVX  
   
  -1.07%
•   HYMC  
   
  +3.94%

$CRVS Corvus Pharmaceuticals is the clear standout on the day after exploding to an eight-year high on exceptionally strong volume that dwarfed its historical average. The catalyst is promising clinical data in eczema, a large and competitive indication where meaningful efficacy signals can quickly reshape a small biotech valuation. Traders are reacting not only to the data itself but to the implied optionality around partnerships, expanded trials, and renewed institutional interest after years off the radar.

$AKAN Akanda surged after announcing a $7 million private placement via convertible notes, a move that eased near-term liquidity concerns and bought management time to execute. In micro-cap names, balance sheet risk often weighs more than fundamentals, so the market response suggests relief rather than enthusiasm about growth. The heavy volume relative to average points to fast-money traders stepping in, but sustainability will depend on how investors view dilution risk and whether operational progress follows the financing headline.

$RMTI Rockwell Medical rallied sharply after preliminary Q4 sales topped expectations, a classic example of fundamentals briefly overpowering skepticism in a thinly followed healthcare name. The stock traded nearly one hundred times its usual volume, signaling that traders are repricing near-term revenue visibility rather than long-term narratives. For now, this is a momentum-driven revaluation tied to execution, and follow-through will depend on whether confirmed results and guidance support the early read-through.

$HYMC Hymc has quietly put together a seven-day winning streak, drawing in momentum traders who thrive on technical strength and rising participation. With volume above average but not extreme, this looks more like a steady accumulation story than a single news-driven spike. In the absence of a fresh catalyst, sentiment and price action are doing most of the work, which can continue in strong tape conditions but can reverse quickly if risk appetite fades.

$ACHC Acadia Healthcare jumped after naming Debra Osteen as CEO while reaffirming guidance, a combination that reassured investors looking for stability and execution in a challenging healthcare services environment. Leadership clarity matters in this space, especially when paired with unchanged outlooks, and the market treated the announcement as a de-risking event rather than a speculative bet. Elevated volume suggests institutions were active, potentially repositioning after a period of underperformance.

$SERV Serve Robotics slid as investors digested an optimistic long-term narrative that still comes with significant execution and funding uncertainty. Despite talk of multibillion-dollar ambition, traders focused on what is not yet proven, particularly scalability and path to profitability. The near-average volume indicates this was more of a sentiment reset than panic selling, with valuation expectations cooling after prior enthusiasm.

$JACK Jack in the Box fell following a rating downgrade that reinforced concerns about brand momentum, margins, and competitive pressure in quick-service restaurants. With no positive catalyst to counter the bearish framing, sellers stayed in control. Lower-than-average volume suggests conviction selling rather than forced liquidation, which often signals continued caution rather than a quick bounce.

$ENVX Enovix dropped after announcing the retirement of its COO just as it approaches mass production, a sensitive timing issue for investors focused on execution risk. Leadership transitions are rarely welcomed at critical operational inflection points, and the stock above-average volume reflects growing unease about manufacturing readiness and continuity. Until clarity improves, traders are likely to treat rallies as selling opportunities.

$VVPR VivoPower slipped despite bullish macro commentary around data center infrastructure, highlighting how company-specific factors can override sector tailwinds. The market appears unconvinced that broad AI-driven demand translates directly into near-term upside for this name. Light volume reinforces the idea that interest is fading rather than aggressively bearish.

$VCIG VCI Global was the day weakest performer after announcing a $5 million registered direct offering, reviving dilution fears in an already fragile chart. With the stock trading under a dollar and volume near average, the decline reflects structural pressure rather than surprise. This remains a capital-structure story first and a growth story second.

View All Headlines